Warfarin DNA Testing Reimbursement Public Comment DEADLINE Wednesday 9/3/08

Here is a recent email sent by Genelex’s CEO, Howard Coleman to people with an interest in personalized medicine:    It’s time to express your opinion on whether warfarin (Coumadin) DNA testing should be paid for by insurance. The Center for Medicare and Medicaid Services (CMS) has initiated a study of this topic and is accepting [...]

Follow

Get every new post delivered to your Inbox.